LogoCrystal's MCW Coder Hub

H46.9

55 min read

📋 Short Definition

Unspecified optic neuritis

Long Definition

ICD-10-CM code H46.9 identifies optic neuritis of unspecified type, which is an acute or subacute inflammatory condition affecting the optic nerve, characterized by sudden vision loss, eye pain (particularly with eye movement), and characteristic findings on ophthalmologic examination including relative afferent pupillary defect (RAPD) and variable optic disc appearance ranging from normal (retrobulbar neuritis) to swollen (papillitis or optic disc edema). Optic neuritis represents inflammation and demyelination of the optic nerve, most commonly affecting the portion of the nerve between the eye and the brain (retrobulbar segment), though it can affect any segment of the optic nerve from the optic disc to the optic chiasm. The condition is strongly associated with demyelinating diseases, particularly multiple sclerosis (MS), with optic neuritis being the presenting symptom in approximately 15-20% of patients who are eventually diagnosed with MS, and occurring at some point during the disease course in 50% or more of MS patients.

The pathophysiology involves autoimmune-mediated inflammation targeting the myelin sheath surrounding optic nerve axons, leading to demyelination, disruption of axonal conduction, and potential axonal injury. This inflammatory process results in acute impairment of visual function, with patients experiencing various patterns and degrees of vision loss, ranging from mild blurring to complete blindness in the affected eye, though vision loss is rarely permanent. The hallmark clinical triad of optic neuritis consists of: (1) subacute monocular vision loss developing over hours to days and typically worsening over 1-2 weeks before stabilizing and beginning to improve; (2) pain on eye movement or retro-orbital pain, present in approximately 90% of cases and often preceding visual symptoms; and (3) dyschromatopsia (impaired color vision), particularly affecting red color perception, which is often more pronounced than visual acuity loss would predict.

Optic neuritis most commonly affects young adults between ages 20-45 years, with a strong female predominance (3:1 female to male ratio), and is more common in Caucasians, particularly those of Northern European descent. The Optic Neuritis Treatment Trial (ONTT), a landmark multicenter randomized controlled trial, established that most patients with typical optic neuritis experience spontaneous improvement in vision over weeks to months, with approximately 60% regaining normal or near-normal visual acuity (20/20 or better) within one year, though subtle deficits in contrast sensitivity, color vision, and visual field may persist. The ONTT also demonstrated that treatment with high-dose intravenous methylprednisolone (1 gram daily for 3 days) followed by oral prednisone taper accelerates visual recovery but does not affect final visual outcome, while oral prednisone alone (without initial IV steroids) was associated with increased recurrence rates and should not be used. Atypical features that suggest alternative diagnoses or require more aggressive workup include: bilateral simultaneous involvement, severe vision loss (no light perception), lack of pain, absence of improvement within 2-3 weeks, severe optic disc edema or hemorrhages, retinal exudates (suggesting neuroretinitis), older age (over 50) or very young age (under 15), no light perception vision, disc pallor at presentation, or progressive vision loss beyond 2 weeks.

Diagnosis is primarily clinical based on characteristic symptoms and examination findings, supported by ancillary testing including MRI of brain and orbits with gadolinium contrast (showing optic nerve enhancement and potentially white matter lesions suggesting MS), visual evoked potentials (demonstrating prolonged P100 latency indicating demyelination), optical coherence tomography (OCT showing peripapillary retinal nerve fiber layer swelling acutely and subsequent thinning), and visual field testing (showing various patterns of defects). The differential diagnosis includes ischemic optic neuropathy (arteritic and non-arteritic), compressive lesions, infectious causes, other inflammatory conditions ([[neuromyelitis optica spectrum disorder, sarcoidosis, systemic lupus erythematosus]]), and toxic/nutritional optic neuropathies.

Code H46.9 is used when optic neuritis is diagnosed but the specific type is not documented (papillitis vs retrobulbar) or when the etiology is unclear or under investigation. When specific subtypes are documented, more specific codes should be used: H46.0- for optic papillitis (inflammation with visible disc swelling), H46.1- for retrobulbar neuritis (inflammation without visible disc changes), H46.2 for nutritional optic neuropathy, or H46.3 for toxic optic neuropathy. The unspecified code H46.9 should be used when documentation does not specify these distinctions or when the patient is in the acute phase and full characterization is not yet complete. Long-term prognosis is generally favorable for vision recovery, though risk of MS development remains significant (approximately 50% of women with optic neuritis and abnormal brain MRI will develop MS within 15 years). Patients require neurologic follow-up and periodic brain MRI surveillance to monitor for MS development, and may be candidates for disease-modifying therapy if MS is diagnosed or if MRI shows asymptomatic lesions suggesting high risk of conversion. This code requires clear clinical documentation of optic neuritis with characteristic features but without specification of the exact subtype, laterality, or underlying etiology.

Area of Body

Optic nerve (cranial nerve II) - unilateral or bilateral involvement:

Optic Nerve Anatomy:

Structure and Location:

  • Cranial nerve II (second cranial nerve)
  • Transmits visual information from retina to brain
  • Length: Approximately 50mm (5cm) from eye to optic chiasm
  • Axon count: ~1.2 million retinal ganglion cell axons
  • Four anatomic segments:
    1. Intraocular (optic disc/optic nerve head): 1mm, visible on fundoscopy
    2. Intraorbital: 25-30mm, within orbit, most common site of optic neuritis
    3. Intracanalicular: 4-10mm, passes through optic canal in sphenoid bone
    4. Intracranial: 10mm, from optic canal to optic chiasm
Myelin Sheath:
  • Optic nerve axons myelinated by oligodendrocytes (central nervous system myelin)
  • Similar to brain white matter myelin (different from peripheral nerve Schwann cell myelin)
  • Target of autoimmune attack in demyelinating diseases
  • Myelin provides electrical insulation for rapid nerve conduction
  • In optic neuritis: Autoimmune inflammation attacks myelin → demyelination → conduction block → vision loss
Blood Supply:
  • Ophthalmic artery (branch of internal carotid artery)
  • Posterior ciliary arteries supply optic nerve head
  • Pial vessels supply orbital and intracanalicular portions
  • Vulnerable to ischemia (different pathology from optic neuritis)
Optic Nerve Sheath:
  • Continuation of meninges (dura, arachnoid, pia mater)
  • Contains cerebrospinal fluid
  • In optic neuritis: May show enhancement on MRI
  • Can show thickening/inflammation (perineuritis)

Pathophysiology of Optic Neuritis:

Inflammatory Process:
  • Autoimmune-mediated inflammation targeting myelin
  • T-cell infiltration of optic nerve
  • Breakdown of blood-brain barrier
  • Cytokine release (inflammatory mediators)
  • Demyelination: Loss of myelin sheath around axons
  • Conduction block: Demyelinated axons cannot transmit signals properly → vision loss
  • Axonal injury: Varying degrees of permanent axonal damage
In Multiple Sclerosis-Associated Optic Neuritis:
  • Similar pathology to MS brain lesions
  • Autoimmune attack against myelin basic protein, MOG (myelin oligodendrocyte glycoprotein), other myelin components
  • Inflammatory plaques form in optic nerve
  • Remyelination can occur (partial recovery)
  • Axonal loss causes permanent damage

Types by Location:

1. Retrobulbar Neuritis (Most Common - ~2/3 of Cases):

  • Inflammation posterior to optic disc (intraorbital segment)
  • Optic disc appears NORMAL on initial examination (classic “patient sees nothing, doctor sees nothing”)
  • Inflammation not visible on fundoscopy
  • Diagnosis based on clinical features (pain, RAPD, vision loss)
  • MRI shows optic nerve enhancement
  • Code H46.1- if specifically documented

2. Optic Papillitis (Anterior Optic Neuritis - ~1/3 of Cases):

  • Inflammation at optic disc (intraocular segment)
  • Optic disc SWOLLEN and HYPEREMIC on examination
  • Visible disc edema on fundoscopy
  • May have peripapillary hemorrhages
  • More common in children
  • Code H46.0- if specifically documented

3. Neuroretinitis:

  • Special form: Optic disc swelling + macular star exudate
  • Often infectious etiology (cat scratch disease, Lyme, syphilis)
  • Different pathophysiology than typical demyelinating optic neuritis
  • Usually NOT associated with MS

Clinical Effects:

Vision Loss Mechanisms:

  • Demyelination → conduction block → signals don’t reach brain
  • Axonal injury → permanent fiber loss
  • Inflammation/edema → compression, ischemia

Visual Function Affected:

  • Visual acuity: Ranges from 20/20 to no light perception; often 20/50 to 20/200
  • Contrast sensitivity: Markedly reduced (often worse than acuity suggests)
  • Color vision: Red desaturation prominent (Ishihara plates, red cap test)
  • Visual field: Various patterns (central scotoma, diffuse depression, arcuate defects, altitudinal defects)
  • Light brightness: Affected eye perceives light as dimmer

Optic Disc Appearance:

Retrobulbar Neuritis (2/3 of cases):

  • Normal-appearing disc initially
  • May develop pallor later (2-4 weeks) if significant axonal loss

Papillitis (1/3 of cases):

  • Disc edema: Blurred margins, swollen, elevated
  • Hyperemia: Pink/red appearance
  • Possible peripapillary hemorrhages (uncommon)
  • Disc appearance similar to papilledema but unilateral (usually)

Relative Afferent Pupillary Defect (RAPD) - HALLMARK:

  • Marcus Gunn pupil
  • Asymmetric pupil response to swinging flashlight test
  • Affected eye’s pupil dilates when light swung from normal to affected eye
  • Indicates optic nerve dysfunction
  • Present in virtually all cases of unilateral optic neuritis
  • Absent if bilateral symmetric involvement

Retinal Nerve Fiber Layer (RNFL):

  • Acutely: Swelling/thickening on OCT (if papillitis)
  • Chronically (weeks-months later): Thinning/atrophy from axonal loss
  • Average RNFL thickness reduced by ~20 microns after optic neuritis episode
  • Correlates with visual outcome

Ganglion Cell Layer:

  • Macular ganglion cell-inner plexiform layer (GC-IPL) thinning
  • Detectable on OCT
  • Indicates neuronal damage

Not Primarily Affected:

  • Retina: Usually structurally normal (except RNFL)
  • Lens, cornea, anterior segment: Normal
  • Extraocular muscles: Normal motility (eye movement itself normal, but causes pain)
  • Brain (initially): May have asymptomatic lesions if MS

Associated Neurologic Involvement (If MS):

  • Brain white matter lesions (periventricular, juxtacortical, infratentorial)
  • Spinal cord lesions
  • Other cranial nerves (rarely at optic neuritis presentation)
  • Motor, sensory, cerebellar pathways (if MS develops)

Laterality in Optic Neuritis:

  • Usually UNILATERAL (90% of typical MS-associated optic neuritis)
  • Bilateral simultaneous involvement UNCOMMON (5-10% typical ON)
    • More common in children
    • Should raise suspicion for:
      • Neuromyelitis optica spectrum disorder (NMOSD)
      • MOG antibody disease
      • Infectious/inflammatory causes
  • Sequential bilateral involvement (different times) occurs in ~20-30% over years
  • H46.9 does NOT specify laterality; use more specific codes if laterality documented

Clinical Presentation and Diagnosis

Patient Presentation:

Typical Presentation (Classic Triad):

1. Vision Loss (HALLMARK):

  • Onset: Subacute, developing over hours to days
  • Progression: Typically worsens over 1-2 weeks, then plateaus before improving
  • Severity: Variable
    • Mild: Blurring, “foggy vision” (20/20 to 20/40)
    • Moderate: 20/50 to 20/200
    • Severe: Counting fingers, hand motion, light perception
    • Very severe: No light perception (rare in typical MS-associated ON; suggests alternative diagnosis)
  • Pattern: Usually monocular (one eye)
  • Character:
    • “Dim” vision
    • “Washed out” colors
    • “Like looking through smudged glasses”
    • Central blur with peripheral vision relatively preserved (if central scotoma)
  • Typically DOES improve over weeks to months (unlike stroke)

2. Eye Pain (Present in ~90%):

  • Pain on eye movement (pathognomonic feature)
    • Worsens with eye movements in any direction
    • “Hurts to look around”
  • Retro-orbital pain: Dull ache behind the eye
  • Often precedes vision loss by hours to days
  • May persist for days to weeks
  • Ranges from mild to severe
  • Absence of pain should raise suspicion for alternative diagnosis

3. Dyschromatopsia (Color Vision Impairment):

  • Red desaturation most prominent
    • “Red doesn’t look as bright”
    • Red cap test: Red object appears “washed out” or “orange” in affected eye
  • Disproportionate to visual acuity loss
  • May be only symptom in very mild cases
  • Ishihara color plates show deficits
Additional Common Symptoms:

Uhthoff Phenomenon (Heat Sensitivity):

  • Worsening of vision with increased body temperature
  • Exercise, hot shower, fever worsen vision temporarily
  • Due to heat-induced conduction block in demyelinated nerve
  • Highly suggestive of demyelinating disease
  • Vision returns to baseline when cooled

Photopsias:

  • Brief flashes of light
  • Often with eye movement
  • “Sparkles” or “lightning streaks”
  • Due to mechanical stimulation of inflamed nerve

Pulfrich Phenomenon:

  • Illusion of depth when object moving in straight line appears to move in arc
  • Due to asymmetric conduction between two eyes

Patient Demographics:

  • Age: 20-45 years (peak incidence 30s)
  • Sex: Female > Male (3:1 ratio)
  • Race: Caucasian (especially Northern European) > African American, Hispanic, Asian
  • Geographic: Higher prevalence at higher latitudes
History Questions:

Timing:

  • When did vision loss start? (acute onset over hours to days typical)
  • How fast did it progress? (1-2 weeks worsening typical)
  • Any improvement yet? (begins 2-4 weeks after onset)
  • Preceded by illness or infection? (sometimes)

Associated Symptoms:

  • Eye pain? Worse with eye movement? (90% yes)
  • Both eyes or one eye? (usually one)
  • Color vision problems? (yes, common)
  • Flashes of light? (common)
  • Worsening with heat/exercise? (Uhthoff phenomenon)

Neurologic Symptoms (MS Screening):

  • Numbness or tingling? (sensory symptoms)
  • Weakness? (motor symptoms)
  • Balance problems, clumsiness? (cerebellar symptoms)
  • Bladder/bowel changes? (autonomic symptoms)
  • Double vision? (internuclear ophthalmoplegia, cranial nerve palsy)
  • Previous similar episodes? (relapsing-remitting course)

Past Medical History:

  • Prior episodes of optic neuritis? (recurrent)
  • Known multiple sclerosis or other autoimmune disease?
  • Recent infections? (post-infectious ON)
  • Medications? (especially ethambutol, isoniazid - toxic optic neuropathy)
  • Alcohol use? (nutritional optic neuropathy)
  • Systemic lupus erythematosus, sarcoidosis, other inflammatory conditions?
Physical/Ophthalmologic Examination:

Visual Acuity:

  • Reduced in affected eye (typically)
  • Range: 20/20 (mild) to no light perception (severe)
  • Most common: 20/50 to 20/200
  • May be near-normal in very mild cases
  • Test each eye separately

Pupillary Examination - ESSENTIAL:

  • Relative Afferent Pupillary Defect (RAPD) - HALLMARK FINDING
  • Swinging flashlight test:
    • Light shined in normal eye: Both pupils constrict equally
    • Light swung to affected eye: Both pupils DILATE (paradoxical)
    • Indicates decreased afferent input from affected optic nerve
  • RAPD present in virtually ALL cases of unilateral optic neuritis
  • Absence of RAPD with vision loss suggests:
    • Bilateral symmetric involvement
    • Refractive error
    • Malingering
    • Retinal pathology (not optic nerve)
  • Critical for diagnosis

Color Vision Testing:

  • Ishihara color plates: Reduced in affected eye
  • Red desaturation test:
    • Show red object to each eye separately
    • “Which eye sees this as more red?”
    • Affected eye perceives red as “washed out,” “orange,” or “pink”
  • Markedly abnormal even if visual acuity only mildly reduced

Visual Field Testing:

  • Patterns variable:
    • Central scotoma (most common): Blur in center of vision
    • Diffuse depression: Overall dimming
    • Arcuate scotomas: Arc-shaped defects
    • Altitudinal defects: Superior or inferior half
    • Hemianopia (rare, suggests chiasmal involvement)
  • Amsler grid: May show central distortion
  • Automated perimetry (Humphrey): Quantifies defects if available
Fundus Examination (Dilated):

Retrobulbar Neuritis (2/3 of cases):

  • Optic disc appears NORMAL initially
  • No disc edema, no hyperemia
  • “Patient sees nothing, doctor sees nothing” (classic saying)
  • Diagnosis based on clinical features, not fundus appearance
  • Later (weeks): May develop optic atrophy (pallor)

Optic Papillitis (1/3 of cases):

  • Optic disc edema:
    • Blurred disc margins
    • Disc elevation (swollen)
    • Hyperemia (pink or red disc)
  • Possible peripapillary hemorrhages (uncommon)
  • Appearance similar to papilledema but:
    • Usually unilateral (papilledema bilateral)
    • Vision loss present (papilledema normal vision initially)
    • RAPD present
  • More common in children and NMOSD

Retina:

  • Usually normal (no retinal pathology)
  • If retinal exudates present → consider neuroretinitis (different diagnosis)
  • Macular edema rare

Extraocular Motility:

  • Full range of motion (muscles function normally)
  • Pain with eye movements (but movement itself intact)
  • Distinguish from cranial nerve palsy (has restricted movement)

Slit Lamp Examination:

  • Usually normal anterior segment
  • No anterior chamber inflammation (uveitis)
  • No corneal abnormalities

Neurologic Examination:

  • Other cranial nerves: Test all (II-XII)
  • Motor: Strength, tone, coordination
  • Sensory: Light touch, pinprick, proprioception
  • Reflexes: Deep tendon reflexes, Babinski
  • Cerebellar: Finger-to-nose, heel-to-shin, gait
  • Purpose: Identify other neurologic deficits suggesting MS or other neurologic disease

Diagnostic Testing:

MRI Brain and Orbits with Gadolinium Contrast - ESSENTIAL:

Purpose:

  • Confirm optic neuritis diagnosis (optic nerve enhancement)
  • Assess for MS risk (white matter lesions)
  • Rule out compressive lesions, tumors

Optic Nerve Findings:

  • Optic nerve enhancement (T1 post-contrast)
    • Confirms active inflammation
    • Sensitivity ~90% in acute phase
    • May involve optic nerve sheath (perineural enhancement)
  • T2 hyperintensity (increased signal on T2/STIR sequences)
  • Optic nerve enlargement/swelling
  • Length of involvement: Varies (short segment to entire nerve)

Brain Findings - MS Risk Stratification:

  • Normal brain MRI: Lower MS risk (~25% at 15 years)
  • Abnormal brain MRI (white matter lesions): Higher MS risk (~72% at 15 years)
  • MS-suggestive lesions:
    • Periventricular location
    • Ovoid shape (Dawson fingers)
    • Perpendicular to corpus callosum
    • Juxtacortical (touching cortex)
    • Infratentorial (brainstem, cerebellum)

    • 3 lesions significantly increases MS risk

  • Typical MS lesion characteristics:
    • T2/FLAIR hyperintense
    • T1 hypointense if severe (black holes)
    • May enhance acutely if active

According to ONTT:

  • 0 brain lesions: 16% MS risk at 5 years, 22% at 10 years
  • 1-2 brain lesions: 37% at 5 years, 51% at 10 years
  • ≄3 brain lesions: 51% at 5 years, 78% at 15 years

Spine MRI:

  • Not routinely done for isolated optic neuritis
  • May be ordered if:
    • High suspicion for MS
    • Neurologic symptoms suggesting myelopathy
    • Abnormal brain MRI
  • Cervical/thoracic spine lesions support MS diagnosis

Visual Evoked Potentials (VEP):

  • Tests visual pathway function from retina to occipital cortex
  • Findings in optic neuritis:
    • Prolonged P100 latency (delayed response)
      • Normal: ~100 milliseconds
      • Optic neuritis: >115-120 milliseconds (prolonged)
    • Reduced amplitude if severe axonal loss
    • Prolongation out of proportion to amplitude reduction suggests demyelination
  • Utility:
    • Confirms optic nerve dysfunction when clinical findings subtle
    • Documents objective abnormality
    • May detect subclinical involvement of fellow eye
  • Limitations:
    • Non-specific (doesn’t distinguish cause)
    • Doesn’t change acute management
    • Not required for diagnosis if clinical features classic

Optical Coherence Tomography (OCT):

  • Non-invasive retinal imaging
  • Acute phase (0-2 weeks):
    • RNFL thickening (if papillitis) - average >100-110 microns
    • Optic disc swelling visible
  • Chronic phase (2-6 months after):
    • RNFL thinning - average reduced by ~20 microns
    • GC-IPL thinning (ganglion cell-inner plexiform layer)
    • Degree of thinning correlates with:
      • Visual outcome
      • Severity of axonal loss
      • MS disease burden
  • Utility:
    • Documents structural damage
    • Baseline for monitoring
    • Prognostic information
    • Detects subclinical involvement

Blood Tests:

  • Not routine for typical optic neuritis
  • Consider if atypical features:
    • AQP4-IgG (aquaporin-4 antibody): Neuromyelitis optica spectrum disorder (NMOSD)
      • Positive in ~70-80% NMOSD
      • If optic neuritis severe, bilateral, or recurrent → test
    • MOG-IgG (myelin oligodendrocyte glycoprotein antibody): MOG antibody disease
      • Causes severe optic neuritis, often bilateral
      • Disc edema common
      • Better prognosis than NMOSD but may recur
    • ACE level, lysozyme: Sarcoidosis (if systemic features)
    • ANA, dsDNA: Systemic lupus erythematosus
    • ESR/CRP: Elevated in inflammatory conditions
    • Syphilis serology (RPR, FTA-ABS): Syphilitic optic neuritis
    • Lyme serology: Lyme disease (endemic areas)
    • Complete blood count, comprehensive metabolic panel: Baseline

Lumbar Puncture (Spinal Tap):

  • Not routine for isolated typical optic neuritis
  • Consider if:
    • Atypical features
    • Suspected MS and MRI not diagnostic
    • Ruling out infectious/inflammatory causes
  • CSF findings in MS:
    • Oligoclonal bands present in ~85-95% MS
    • Elevated IgG index
    • Mild lymphocytic pleocytosis (<50 cells)
    • Normal or mildly elevated protein
  • CSF findings in NMOSD:
    • Often more inflammatory (higher WBC, protein)
    • May have neutrophils
  • Infectious evaluation: Cultures, PCR, serology as indicated
Diagnostic Criteria for Optic Neuritis:

Clinical Diagnosis (Does NOT Require MRI):

  1. Subacute monocular vision loss (hours to days onset)
  2. Pain on eye movement or retro-orbital pain (90%)
  3. Relative afferent pupillary defect (RAPD) (if unilateral)
  4. Dyschromatopsia (color vision impairment)
  5. Normal or swollen optic disc (retrobulbar vs papillitis)
  6. Age 15-50 years (typical)

MRI Confirmation:

  • Optic nerve enhancement and/or T2 hyperintensity
  • NOT required if clinical picture classic
Atypical Features (Suggest Alternative Diagnosis or Warrant Extended Workup):

Red Flags:

  • Bilateral simultaneous onset (consider NMOSD, MOG-antibody disease, infectious)
  • No light perception vision (very severe; atypical for MS-related ON)
  • Severe disc edema with hemorrhages, exudates (neuroretinitis, NMOSD)
  • Painless (10% typical ON painless, but raises suspicion)
  • Absence of improvement by 2-4 weeks (consider compressive lesion, NMOSD)
  • Progressive worsening beyond 2 weeks (compressive lesion, infiltrative process)
  • Age >50 years (consider ischemic optic neuropathy, GCA)
  • Age <10 years (post-infectious, ADEM)
  • Optic disc pallor at presentation (chronic process, not acute)
  • Retinal exudates (neuroretinitis, not typical ON)

Differential Diagnosis:

Must Rule Out:

Ischemic Optic Neuropathy:

  • Non-arteritic (NAION): Most common optic neuropathy in patients >50
    • Painless vision loss (unlike ON)
    • Sudden onset (wake up with vision loss)
    • Disc edema with “disc at risk” (small cup) in fellow eye
    • Altitudinal visual field defect common
    • Risk factors: Hypertension, diabetes, sleep apnea
    • NO pain on eye movement
    • NO improvement expected
  • Arteritic (AAION - Giant Cell Arteritis):
    • Age >50 (usually >70)
    • Severe sudden vision loss
    • Systemic symptoms: Headache, jaw claudication, scalp tenderness, fever, weight loss, PMR
    • Markedly elevated ESR/CRP
    • EMERGENCY - risk of bilateral blindness if untreated
    • Treat immediately with high-dose steroids before biopsy
    • Code: H47.01- (ischemic optic neuropathy), not H46.9

Compressive Optic Neuropathy:

  • Tumor, aneurysm, thyroid eye disease
  • Progressive vision loss (not subacute)
  • May have other neurologic signs
  • Usually painless
  • MRI shows mass lesion compressing nerve
  • Requires surgical evaluation

Neuromyelitis Optica Spectrum Disorder (NMOSD - Devic Disease):

  • More severe optic neuritis than typical MS-related
  • Often bilateral, severe vision loss (NLP common)
  • Severe disc edema
  • Often recurrent
  • Associated with longitudinally extensive transverse myelitis (spinal cord involvement ≄3 vertebral segments)
  • AQP4-IgG positive in ~70-80%
  • Worse prognosis than MS-related ON (less recovery)
  • Requires different treatment (rituximab, immunosuppression)
  • Code: G36.0 (neuromyelitis optica), not H46.9

MOG-Antibody Associated Disease:

  • MOG-IgG positive
  • Optic neuritis often severe, bilateral
  • Prominent disc edema
  • May have concurrent ADEM-like features
  • Better visual recovery than NMOSD but may recur
  • Requires immunosuppression if recurrent
  • Different entity from MS and NMOSD

Neuroretinitis:

  • Optic disc edema PLUS macular star exudate
  • Often infectious: Cat scratch disease (Bartonella), Lyme, syphilis, toxoplasmosis
  • Good visual prognosis with treatment of infection
  • Different pathophysiology (vascular leak vs demyelination)

Posterior Uveitis:

  • Intraocular inflammation
  • Anterior chamber cells/flare on slit lamp
  • Vitreous cells
  • Disc may be swollen but primary pathology is uveal inflammation
  • Systemic workup for uveitis etiology

Toxic Optic Neuropathy:

  • Medications: Ethambutol, isoniazid, linezolid, amiodarone
  • Toxins: Methanol, ethylene glycol
  • Tobacco-alcohol (nutritional)
  • Usually bilateral, painless, progressive
  • Code: H46.3 (toxic optic neuropathy)

Nutritional Optic Neuropathy:

  • Vitamin B12 deficiency (most common)
  • Folate, thiamine deficiency
  • Usually bilateral, painless, progressive (not acute)
  • Central or cecocentral scotomas
  • Code: H46.2 (nutritional optic neuropathy)

Hereditary Optic Neuropathies:

  • Leber hereditary optic neuropathy (LHON):
    • Mitochondrial inheritance
    • Painless, subacute, sequential bilateral vision loss
    • Young males predominantly
    • Characteristic genetic mutations
  • Code: H47.22 (hereditary optic atrophy)

Functional Vision Loss (Malingering/Conversion):

  • Normal pupil reactions (no RAPD)
  • Inconsistent examination findings
  • “Tubular” visual fields
  • Normal VEP

Includes

This Code Encompasses:

  • Optic neuritis, type not specified
  • Optic nerve inflammation, unspecified
  • Demyelinating optic neuritis, unspecified type
  • Acute optic neuritis without specification of papillitis vs retrobulbar
  • Idiopathic optic neuritis (cause unknown)
  • Optic neuritis under investigation (etiology not yet determined)
  • Optic neuritis associated with multiple sclerosis when MS diagnosis not yet confirmed

Clinical Scenarios:

  • Patient with acute vision loss, eye pain, RAPD consistent with optic neuritis, but documentation doesn’t specify retrobulbar vs papillitis
  • Patient with optic neuritis confirmed clinically but MRI not yet done and type uncertain
  • Optic neuritis of presumed demyelinating etiology but awaiting MS workup
  • Recurrent optic neuritis, type unspecified
  • Optic neuritis, laterality not documented (though specific codes exist if laterality known)

Excludes

Excludes2 (May Code Together if Both Present):

At H46 Category Level:

  • H47.01- - Ischemic optic neuropathy (arteritic or non-arteritic)
    • Different pathophysiology: Vascular occlusion, not inflammation/demyelination
    • Usually painless (vs ON with pain)
    • Older age, sudden onset, risk factors (hypertension, diabetes, GCA)
    • If ischemic neuropathy present, use H47.01- code instead of H46.9
  • G36.0 - Neuromyelitis optica [Devic disease]
    • Specific severe demyelinating disorder
    • Optic neuritis + longitudinally extensive transverse myelitis
    • AQP4-IgG positive
    • If NMO diagnosed, use G36.0 as primary diagnosis (may add optic neuritis code as secondary if documenting eye involvement)
More Specific Optic Neuritis Codes (Use Instead of H46.9 if Documented):

H46.0- - Optic Papillitis:

  • With laterality specificity:
  • Use when documentation specifies papillitis (optic disc swelling/inflammation visible)
  • More specific than H46.9

H46.1- - Retrobulbar Neuritis:

  • With laterality specificity:
  • Use when documentation specifies retrobulbar neuritis (optic nerve inflammation posterior to disc, disc appears normal)
  • More specific than H46.9

H46.2 - Nutritional Optic Neuropathy:

  • Optic neuropathy due to vitamin deficiency (B12, folate, thiamine)
  • Tobacco-alcohol amblyopia
  • Different etiology than inflammatory/demyelinating
  • If nutritional cause documented, use H46.2 instead of H46.9

H46.3 - Toxic Optic Neuropathy:

  • Drug-induced: Ethambutol, isoniazid, linezolid, amiodarone
  • Toxin-induced: Methanol, ethylene glycol
  • Different etiology than inflammatory
  • If toxic cause documented, use H46.3 instead of H46.9

H46.8 - Other Optic Neuritis:

  • Specified types not elsewhere classified
  • Use if specific type documented but doesn’t fit H46.0-, H46.1-, H46.2, H46.3

Other Related Codes (Different Diagnoses):

  • H47.01- - Ischemic optic neuropathy (discussed above)
  • H47.1- - Papilledema (disc swelling from increased intracranial pressure, not inflammation)
  • H47.2- - Optic atrophy (end-stage, chronic; not acute inflammation)
  • G36.0 - Neuromyelitis optica (discussed above)
  • G36.1 - Acute and subacute hemorrhagic leukoencephalitis
  • G35.- - Multiple sclerosis (if MS diagnosed, code as primary or comorbidity)

Coding Guidance:

  • H46.9 is unspecified/default code for optic neuritis
  • Use more specific codes (H46.0-, H46.1-, H46.2, H46.3, H46.8) when type documented
  • If laterality documented and specific type known, use 4-character code (e.g., H46.11 for retrobulbar neuritis, right eye)
  • Do NOT use H46.9 if:
    • Ischemic optic neuropathy present (use H47.01-)
    • Nutritional cause documented (use H46.2)
    • Toxic cause documented (use H46.3)
    • Specific type (papillitis or retrobulbar) documented (use H46.0- or H46.1-)
  • May use with G35 (MS) or G36.0 (NMO) if those conditions documented as underlying cause

HCC Status

HCC Mapping: Does NOT map to an HCC Category

ICD-10 code H46.9 (unspecified optic neuritis) does NOT map to a Hierarchical Condition Category (HCC) under the CMS-HCC risk adjustment model.

Why Not an HCC:

  • Optic neuritis is acute/episodic condition, not chronic high-cost disease
  • Treatment relatively low-cost (steroids, monitoring)
  • Most patients recover spontaneously
  • Does not predict high ongoing healthcare expenditure
  • Not among HCC categories in CMS models

Associated Conditions May Be HCC:

  • Multiple sclerosis (G35): Some MS codes may map to HCC depending on model version
    • MS requires ongoing disease-modifying therapy (high cost)
    • Optic neuritis itself (H46.9) does not map to HCC
    • MS diagnosis (G35) may have HCC implications
  • Neuromyelitis optica (G36.0): Generally NOT HCC

Clinical Implications:

  • Document H46.9 for clinical accuracy and medical necessity
  • Important for justifying MRI, treatment, follow-up
  • If MS diagnosed, code G35 separately (may have HCC relevance)
  • H46.9 alone does not impact risk adjustment
  • Does not affect Medicare Advantage capitated payments

MS-DRG Status

MS-DRG: 123 - Neurological Eye Disorders

ICD-10 code H46.9 (Unspecified optic neuritis) maps to MS-DRG 123 (Neurological Eye Disorders) when used as the principal diagnosis for an inpatient admission.

MS-DRG 123 Characteristics:

Description: Neurological Eye Disorders

MDC: 02 - Diseases and Disorders of the Eye

Type: Medical DRG (not surgical)

Includes Diagnoses:

  • Optic neuritis (H46.-)
  • Optic nerve disorders (H47.-)
  • Cranial nerve palsies affecting eye (H49.-)
  • Ptosis (H02.4-)
  • Visual field defects (H53.4-)
  • Diplopia (H53.2)
  • Transient/sudden visual loss (H53.12-, H53.13-)
  • Other neurological eye disorders

Typical Length of Stay:

  • Geometric mean LOS: ~2-3 days
  • Arithmetic mean LOS: ~3-4 days

Relative Weight (2026): Approximately 0.6-0.8 (varies by year)

  • Lower weight = lower reimbursement
  • Reflects relatively short stay and limited resource utilization
Inpatient Admission for Optic Neuritis:

When Admission Appropriate:

  • Severe vision loss requiring IV steroids
    • High-dose IV methylprednisolone 1000mg daily x 3 days
    • Observation for steroid side effects
    • Neurologic monitoring
  • First episode concerning for MS
    • Complete MS workup (MRI, LP if indicated)
    • Neurology consultation
    • Patient education
  • Atypical optic neuritis requiring extensive workup
    • Bilateral involvement
    • Severe presentation suggesting NMOSD
    • Rule out compressive lesions, infections
    • AQP4-IgG, MOG-IgG testing
    • Lumbar puncture
  • Associated neurologic symptoms
    • Concern for MS relapse
    • Transverse myelitis
    • Other CNS demyelination
  • Complications
    • Steroid-induced hyperglycemia requiring management
    • Psychiatric symptoms from steroids

Most Cases Managed Outpatient:

  • Typical optic neuritis often treated outpatient
  • Oral steroids or observation
  • Outpatient MRI and follow-up
  • Admission not routine for uncomplicated optic neuritis

Documentation for MS-DRG 123:

  • Principal diagnosis: H46.9 (or more specific H46.- code)
  • Secondary diagnoses:
    • G35 (Multiple sclerosis) if known
    • Complications of steroids (E11.- diabetes, F06.- mood disorder)
    • Other neurologic findings
  • Procedures:
    • IV steroid administration
    • MRI brain/orbits
    • Lumbar puncture (if performed)
    • Ophthalmologic examination
  • Medical necessity for admission:
    • Document why outpatient management insufficient
    • Severity of vision loss
    • Need for IV steroids and monitoring
    • Extensive diagnostic workup required

No CC/MCC Splits for DRG 123:

  • MS-DRG 123 does not split based on complications/comorbidities
  • Single DRG for neurological eye disorders regardless of CC/MCC status
  • Simpler than many other DRGs

Alternative MS-DRGs:

  • If patient admitted for MS relapse with optic neuritis as one manifestation:
    • May map to MS DRG (nervous system DRG) instead of eye DRG
    • Depends on principal diagnosis selected
  • If surgical intervention (rare): Would map to surgical eye DRG

wRVU Status

Not Applicable - ICD-10 diagnosis codes do not have wRVU (work Relative Value Units) values.

wRVUs apply only to CPT procedure codes. ICD-10 codes document the diagnosis.

Ophthalmology/Neurology Examination:

  • 92002 - Intermediate, new patient: 0.92 wRVU
  • 92004 - Comprehensive, new patient: 1.50 wRVU
  • 92012 - Intermediate, established: 0.66 wRVU
  • 92014 - Comprehensive, established: 1.09 wRVU
  • 99202-99205 - Office visit, new patient: 0.92 to 3.17 wRVU (neurology)
  • 99212-99215 - Office visit, established: 0.18 to 1.92 wRVU (neurology)
  • 99281-99285 - Emergency department visit: 0.47 to 3.80 wRVU

Specialized Ophthalmic Testing:

  • 92083 - Visual field examination, extended (Humphrey): 0.53 wRVU
  • 92133 - OCT optic nerve head with interpretation: 0.52 wRVU
  • 92250 - Fundus photography with interpretation: 0.61 wRVU
  • 76514 - Ophthalmic ultrasound (pachymetry, A-scan): 0.25 wRVU

Neuroimaging:

  • 70551 - MRI brain without contrast: 1.36 wRVU (professional component)
  • 70553 - MRI brain with and without contrast: 1.89 wRVU (professional)
  • 70540 - MRI orbits without contrast: 1.36 wRVU (professional)
  • 70543 - MRI orbits with and without contrast: 1.89 wRVU (professional)

Visual Evoked Potentials:

  • 95930 - Visual evoked potential (VEP) testing: 0.83 wRVU

Lumbar Puncture:

  • 62270 - Spinal puncture, lumbar, diagnostic: 1.22 wRVU

Steroid Administration (Inpatient):

  • 96365 - IV infusion, initial, up to 1 hour (methylprednisolone): 0.42 wRVU
  • 96366 - IV infusion, additional hour: 0.37 wRVU

Consultation:

  • 99242-99245 - Office consultation, new patient: 1.19 to 3.86 wRVU (neurology consult)

Assistant Surgeon Status

Not Applicable - ICD-10 diagnosis codes do not have assistant surgeon payment policies.

Optic neuritis (H46.9) is a medical condition managed non-surgically. No surgical procedures typically performed for optic neuritis.

Rarely, if complications require surgery:

  • Optic nerve sheath fenestration (rare, not standard for optic neuritis)
  • Treatment of underlying compressive lesions (if misdiagnosed initially)
  • Assistant surgeon policies would apply to surgical CPT codes, not diagnosis code

Standard Management Non-Surgical:

  • IV steroids
  • Oral steroids
  • Observation
  • Disease-modifying therapy for MS

Common Modifiers

Not Applicable for Diagnosis Code

ICD-10 diagnosis codes do not use CPT modifiers. Modifiers are appended to CPT procedure codes.

Laterality in H46.9:

  • H46.9 does NOT specify laterality (unspecified)
  • More specific codes available if laterality documented:
    • H46.01 (optic papillitis, right eye)
    • H46.02 (optic papillitis, left eye)
    • H46.11 (retrobulbar neuritis, right eye)
    • H46.12 (retrobulbar neuritis, left eye)
  • Laterality should be documented clinically even if coding H46.9

When Billing CPT Procedures: CPT codes may use modifiers:

  • RT - Right side (for unilateral testing/procedures on right eye)
  • LT - Left side (for left eye)
  • 50 - Bilateral procedure (if testing both eyes)
  • 26 - Professional component (for imaging interpretation)
  • TC - Technical component (for imaging equipment)
  • 25 - Significant, separately identifiable E/M service on same day as procedure

Common Associated Codes

ICD-10 CodeDescriptionRelationship to H46.9
H46.00Optic papillitis, unspecified eyeMore specific type (disc swelling)
H46.01Optic papillitis, right eyeSpecific type, right eye
H46.02Optic papillitis, left eyeSpecific type, left eye
H46.03Optic papillitis, bilateralSpecific type, both eyes
H46.10Retrobulbar neuritis, unspecified eyeMore specific type (normal disc appearance)
H46.11Retrobulbar neuritis, right eyeSpecific type, right eye
H46.12Retrobulbar neuritis, left eyeSpecific type, left eye
H46.13Retrobulbar neuritis, bilateralSpecific type, both eyes
H46.2Nutritional optic neuropathyDifferent etiology
H46.3Toxic optic neuropathyDifferent etiology (drug/toxin)
H46.8Other optic neuritisOther specified types
G35Multiple sclerosisMost common associated condition
G36.0Neuromyelitis optica [Devic]Alternative demyelinating disease
H47.011Ischemic optic neuropathy, right eyeDifferent diagnosis (vascular, not inflammatory)
H47.012Ischemic optic neuropathy, left eyeDifferent diagnosis
H53.131-133Sudden visual lossSymptom code
H53.2DiplopiaIf internuclear ophthalmoplegia present
H53.411-413Scotoma involving central areaVisual field defect from optic neuritis
H54.10-13Blindness, one eye, low vision other eyeIf severe vision loss
H54.40-42Blindness, one eyeIf severe unilateral vision loss
R51.9Headache, unspecifiedIf headache present
R52Pain, unspecifiedRetro-orbital pain
ICD-10 CodeDescriptionAssociation
G35Multiple sclerosisPrimary associated disease
G82.20Paraplegia, unspecifiedIf transverse myelitis develops
R26.81Unsteadiness on feetAtaxia from MS
R26.89Other abnormalities of gait and mobilityMS-related
N31.9Neuromuscular dysfunction of bladderMS symptom
F06.31Mood disorder due to known physiological condition with depressive featuresMS-related depression
G89.29Other chronic painNeuropathic pain from MS
Common Associated CPT Procedure Codes:
CPT CodeDescriptionWhen Used with H46.9
92002Ophthalmological examination, intermediate, newInitial evaluation
92004Ophthalmological examination, comprehensive, newComprehensive initial assessment
92012Intermediate, establishedFollow-up visits
92014Comprehensive, establishedFollow-up comprehensive
92083Visual field examination, extended (Humphrey 24-2, 30-2)Quantify visual field defects
92133OCT optic nerve head with interpretationAssess RNFL swelling/thinning
92250Fundus photography with interpretationDocument optic nerve appearance
70551MRI brain without contrastScreen for MS lesions
70553MRI brain with and without contrastPreferred for optic neuritis (shows enhancement)
70540MRI orbits without contrastVisualize optic nerve
70543MRI orbits with and without contrastPreferred for optic neuritis (shows nerve enhancement)
95930Visual evoked potential (VEP) testingConfirm optic nerve dysfunction, detect subclinical involvement
62270Spinal puncture, lumbar, diagnosticIf MS workup, CSF analysis
96365IV infusion, first hour (methylprednisolone)Steroid treatment
96366IV infusion, additional hourContinued steroid infusion
99201]]-99205]]Office visit, new patientNeurology evaluation
99211]]-99215]]Office visit, established patientNeurology follow-up, MS monitoring
99242]]-99245]]]Office consultationNeurology or ophthalmology consult
99281]]-99285]]Emergency department visitAcute presentation to ED

Medications for Optic Neuritis Treatment:

Acute Treatment:

  • IV Methylprednisolone (Solu-Medrol):
    • 1000 mg IV daily x 3 days (ONTT protocol)
    • Followed by oral prednisone taper (1 mg/kg/day x 11 days, then taper)
    • Accelerates recovery but doesn’t improve final outcome
    • Reduces short-term MS risk
  • Oral Prednisone:
    • NOT recommended as sole therapy (ONTT showed increased recurrence)
    • May be used after IV steroids (taper)
    • Typically 1 mg/kg/day tapering over 2-3 weeks

MS Disease-Modifying Therapy (If MS Diagnosed or High Risk):

  • Injectable agents:
    • Interferon beta-1a (Avonex, Rebif)
    • Interferon beta-1b (Betaseron, Extavia)
    • Glatiramer acetate (Copaxone)
  • Oral agents:
    • Dimethyl fumarate (Tecfidera)
    • Teriflunomide (Aubagio)
    • Fingolimod (Gilenya)
    • Siponimod (Mayzent)
    • Ozanimod (Zeposia)
    • Cladribine (Mavenclad)
  • Infusion agents:
    • Natalizumab (Tysabri)
    • Ocrelizumab (Ocrevus)
    • Alemtuzumab (Lemtrada)
    • Rituximab (off-label)

NMOSD Treatment (If NMOSD Diagnosed):

  • Rituximab (Rituxan)
  • Eculizumab (Soliris)
  • Satralizumab (Enspryng)
  • Inebilizumab (Uplizna)
  • Mycophenolate mofetil
  • Azathioprine

Code Tree/Hierarchy

ICD-10-CM Chapter: 7 - Diseases of the Eye and Adnexa (H00-H59)

Block: H46-H47 - Disorders of Optic Nerve and Visual Pathways

Category: H46 - Optic neuritis

Structure:
H46 - Optic neuritis
│
├── H46.0 - Optic papillitis
│   ├── H46.00 - Optic papillitis, unspecified eye
│   ├── H46.01 - Optic papillitis, right eye
│   ├── H46.02 - Optic papillitis, left eye
│   └── H46.03 - Optic papillitis, bilateral
│
├── H46.1 - Retrobulbar neuritis
│   ├── H46.10 - Retrobulbar neuritis, unspecified eye
│   ├── H46.11 - Retrobulbar neuritis, right eye
│   ├── H46.12 - Retrobulbar neuritis, left eye
│   └── H46.13 - Retrobulbar neuritis, bilateral
│
├── H46.2 - Nutritional optic neuropathy
│   └── (No further subdivisions)
│
├── H46.3 - Toxic optic neuropathy
│   └── (No further subdivisions - includes code first if drug-induced)
│
├── H46.8 - Other optic neuritis
│   └── (Specified types not elsewhere classified)
│
└── H46.9 - Unspecified optic neuritis ◄ CURRENT CODE
    └── (No further subdivisions - most non-specific code)

H47 - Other Disorders of Optic Nerve and Visual Pathways:

H47 - Other disorders of optic nerve and visual pathways
│
├── H47.0 - Disorders of optic nerve, not elsewhere classified
│   ├── H47.01 - Ischemic optic neuropathy
│   │   ├── H47.011 - Right eye
│   │   ├── H47.012 - Left eye
│   │   ├── H47.013 - Bilateral
│   │   └── H47.019 - Unspecified eye
│   ├── H47.02 - Hemorrhage in optic nerve sheath
│   ├── H47.03 - Optic nerve hypoplasia
│   └── H47.09 - Other disorders of optic nerve
│
├── H47.1 - Papilledema
│   ├── H47.10 - Unspecified papilledema
│   ├── H47.11 - Papilledema associated with increased intracranial pressure
│   ├── H47.12 - Papilledema associated with decreased ocular pressure
│   └── H47.13 - Papilledema associated with retinal disorder
│
├── H47.2 - Optic atrophy
├── H47.3 - Other disorders of optic disc
├── H47.4 - Disorders of optic chiasm
├── H47.5 - Disorders of other visual pathways
├── H47.6 - Disorders of visual cortex
└── H47.9 - Unspecified disorder of visual pathways
Code Selection Decision Tree:
Patient Presents with Vision Loss?
│
├── Clinical features suggest OPTIC NEURITIS?
│   - Subacute onset (hours to days)
│   - Eye pain, especially with movement
│   - Monocular (usually)
│   - RAPD present
│   - Age 20-45 years
│   - Dyschromatopsia
│   │
│   ├── YES → Optic neuritis likely
│   │   │
│   │   ├── Is SPECIFIC TYPE documented?
│   │   │   │
│   │   │   ├── **PAPILLITIS** (disc swelling visible)?
│   │   │   │   ├── Laterality documented?
│   │   │   │   │   ├── Right eye → H46.01
│   │   │   │   │   ├── Left eye → H46.02
│   │   │   │   │   ├── Bilateral → H46.03
│   │   │   │   │   └── Unspecified → H46.00
│   │   │   │   │
│   │   │   ├── **RETROBULBAR NEURITIS** (disc normal)?
│   │   │   │   ├── Laterality documented?
│   │   │   │   │   ├── Right eye → H46.11
│   │   │   │   │   ├── Left eye → H46.12
│   │   │   │   │   ├── Bilateral → H46.13
│   │   │   │   │   └── Unspecified → H46.10
│   │   │   │   │
│   │   │   ├── **NUTRITIONAL** etiology?
│   │   │   │   └── H46.2 (no laterality)
│   │   │   │
│   │   │   ├── **TOXIC** (drug/toxin)?
│   │   │   │   └── H46.3 (no laterality)
│   │   │   │       └── Code first poisoning due to drug/toxin (T36-T65)
│   │   │   │
│   │   │   ├── **OTHER** specified type?
│   │   │   │   └── H46.8
│   │   │   │
│   │   │   └── **UNSPECIFIED** type/laterality?
│   │   │       └── H46.9 ◄ CURRENT CODE
│   │   │
│   │   └── Is underlying cause identified?
│   │       ├── **Multiple sclerosis** → Add G35 as comorbidity
│   │       ├── **Neuromyelitis optica** → G36.0 (may be primary diagnosis)
│   │       ├── **Post-infectious** → Add infectious disease code
│   │       └── **Idiopathic** → Optic neuritis code alone
│   │
│   └── NO → Consider alternative diagnoses:
│       ├── **Ischemic optic neuropathy?**
│       │   - Painless, sudden onset
│       │   - Age >50
│       │   - Risk factors (HTN, DM, sleep apnea)
│       │   → H47.01- (ischemic optic neuropathy)
│       │
│       ├── **Compressive lesion?**
│       │   - Progressive vision loss
│       │   - Painless
│       │   - Mass on MRI
│       │   → H47.0- (optic nerve disorder)
│       │
│       ├── **Papilledema?**
│       │   - Bilateral disc swelling
│       │   - Increased intracranial pressure
│       │   - Vision initially normal
│       │   → H47.1- (papilledema)
│       │
│       └── **Other optic neuropathy**
│           → Appropriate H47.- code
│
└── Document clearly:
    - Type (papillitis vs retrobulbar)
    - Laterality (right, left, bilateral, unspecified)
    - Etiology (MS, idiopathic, post-infectious, etc.)
    - Associated findings (MRI lesions, CSF findings)
Progression Over Time:
Initial Episode: Optic Neuritis
│
├── Idiopathic (no MS lesions on MRI)
│   - Code: H46.- (optic neuritis)
│   - Follow clinically
│   - Risk of MS development (~25% at 15 years)
│
├── First demyelinating event with MRI lesions
│   - Code: H46.- (optic neuritis) + G35 (if MS diagnosed)
│   - May start disease-modifying therapy
│   - Higher MS risk (~ 72% at 15 years if ≄3 lesions)
│
└── Multiple sclerosis confirmed
    - Code: G35 (MS) as primary + H46.- if optic neuritis active
    - Disease-modifying therapy
    - Ongoing monitoring

Long-term Sequelae (if severe):
│
├── Optic atrophy (chronic)
│   - Code: H47.2- (optic atrophy)
│   - Permanent optic nerve damage
│   - Pallor on fundoscopy
│
├── Persistent visual field defect
│   - Code: H53.4- (visual field defect) + H47.2- (optic atrophy)
│
└── Vision impairment/blindness (severe cases)
    - Code: H54.- (vision impairment/blindness categories)

Coding Examples

Example 1: Classic Optic Neuritis - Unspecified Type (Use H46.9)

Clinical Scenario: 28-year-old female presents to emergency department with 2-day history of vision loss in right eye.

History:

  • Woke up 2 days ago with blurred vision in right eye
  • Progressive worsening over past 48 hours
  • Pain behind right eye, worse when she moves her eyes
  • “Red doesn’t look as bright” with right eye
  • No prior episodes
  • No known medical history
  • No other neurologic symptoms

Examination:

  • Visual acuity: Right eye 20/80, left eye 20/20
  • Pupils: Right pupil shows relative afferent pupillary defect (RAPD) on swinging flashlight test
  • Color vision: Right eye sees red as “washed out” compared to left
  • Visual fields by confrontation: Right central scotoma suspected
  • Fundus examination (dilated): Right optic disc appears normal (no edema), left disc normal
  • Extraocular motility: Full, but right eye painful with all movements
  • Slit lamp: Normal anterior segments bilaterally
  • Neurologic examination: Otherwise normal, no other deficits
Assessment:
  • Optic neuritis, right eye (clinical diagnosis based on classic triad: subacute vision loss, eye pain with movement, RAPD)
  • Normal-appearing disc suggests retrobulbar neuritis, but not explicitly documented
  • Etiology unknown (workup needed)

Plan:

  • MRI brain and orbits with gadolinium (rule out MS, confirm optic neuritis)
  • Consider IV methylprednisolone vs observation
  • Neurology consult
  • Follow-up in 1 week
ICD-10-CM Coding:
  • H46.9 - Unspecified optic neuritis (PRIMARY)
    • Rationale: Optic neuritis clinically diagnosed but specific type (papillitis vs retrobulbar) not explicitly documented in ED note; laterality documented clinically but using unspecified code acceptable when detailed subtype not confirmed

Alternative More Specific Coding (if explicitly documented):

  • If note stated “retrobulbar neuritis, right eye” → H46.11
  • If note stated “optic papillitis” → H46.01

CPT Coding:

  • 99284 - Emergency department visit, high complexity
  • 92004 - Comprehensive ophthalmological examination (if ophthalmology consulted)
  • 70553 - MRI brain with and without contrast (when performed)
  • 70543 - MRI orbits with and without contrast (when performed)

Rationale: H46.9 appropriate when optic neuritis diagnosed clinically with classic features but specific subtype (papillitis vs retrobulbar) not documented or laterality not specified in coding. More specific codes (H46.11 for retrobulbar neuritis, right eye) preferred if documentation supports.

Example 2: Optic Neuritis with MS - First Demyelinating Event

Clinical Scenario: 32-year-old woman admitted for acute vision loss, found to have first demyelinating event.

History:

  • 5-day history of progressive vision loss left eye
  • Severe pain with eye movements
  • Colors “washed out” in left eye

Examination:

  • Visual acuity: Right eye 20/20, left eye 20/200
  • RAPD left eye
  • Fundus: Left optic disc swollen, blurred margins, hyperemic (papillitis)
  • Right eye normal

MRI Brain and Orbits with Gadolinium:

  • Left optic nerve enhancement (confirms optic neuritis)
  • Five periventricular white matter lesions, T2/FLAIR hyperintense
  • Three lesions perpendicular to corpus callosum (Dawson fingers)
  • Consistent with demyelinating disease

Lumbar Puncture:

  • Oligoclonal bands present in CSF (not in serum)
  • Elevated IgG index
  • Mild lymphocytic pleocytosis (12 WBC)

Neurology Assessment:

  • First clinical demyelinating event (optic neuritis)
  • MRI findings consistent with multiple sclerosis
  • Meets 2017 McDonald Criteria for MS
  • Recommend disease-modifying therapy

Treatment:

  • IV methylprednisolone 1000mg daily x 3 days
  • Vision improved to 20/40 by discharge
  • Started dimethyl fumarate (Tecfidera) for MS

Discharge Diagnoses:

  1. Optic papillitis, left eye
  2. Multiple sclerosis, newly diagnosed

ICD-10-CM Coding:

  • G35 - Multiple sclerosis (PRIMARY - newly diagnosed MS)
  • H46.02 - Optic papillitis, left eye (SECONDARY - manifestation of MS)

Alternative if Type Not Specified:

  • G35 - Multiple sclerosis (PRIMARY)
  • H46.9 - Unspecified optic neuritis (SECONDARY)

CPT Coding:

  • 99223 - Initial hospital care, high complexity
  • 70553 - MRI brain with and without contrast
  • 70543 - MRI orbits with and without contrast
  • 62270 - Lumbar puncture
  • 96365 - IV infusion, first hour (methylprednisolone)
  • 99238 - Hospital discharge

MS-DRG:

  • Likely MS-DRG 123 (Neurological Eye Disorders) if H46.02 coded as principal diagnosis
  • OR MS-DRG 057 (Degenerative Nervous System Disorders with MCC) or MS-DRG 058 (without MCC) if G35 coded as principal
  • Principal diagnosis selection determines DRG

Rationale: Multiple sclerosis is the primary diagnosis (underlying disease). Optic papillitis is a manifestation of MS. Code MS (G35) as primary and optic neuritis (H46.02 or H46.9) as secondary. Specific type (papillitis) documented so H46.02 preferred over H46.9.

Example 3: Recurrent Optic Neuritis in Known MS Patient

Clinical Scenario: 40-year-old woman with known MS for 8 years presents with recurrent optic neuritis, right eye.

History:

  • Diagnosed with MS in 2018 after first optic neuritis episode
  • On glatiramer acetate (Copaxone) for MS
  • Generally stable, no relapses for 3 years
  • 3 days ago: New onset vision loss right eye, similar to prior episode
  • Eye pain with movement
  • No other new neurologic symptoms

Examination:

  • Visual acuity: Right eye 20/100, left eye 20/20 (left eye had prior optic neuritis in 2018, residual 20/25)
  • RAPD right eye
  • Right optic disc normal-appearing (retrobulbar neuritis)
  • Right eye red desaturation

MRI Brain/Orbits:

  • Right optic nerve enhancement (acute optic neuritis)
  • Stable chronic white matter lesions (no new brain lesions)
  • Confirms acute optic neuritis; no evidence of MS progression in brain

Assessment:

  • Relapsing-remitting multiple sclerosis with acute exacerbation
  • Retrobulbar neuritis, right eye (new episode)
  • Prior optic neuritis, left eye (2018, residual deficits)

Treatment:

  • IV methylprednisolone 1000mg x 3 days
  • Continue Copaxone
  • Consider changing to higher-efficacy MS therapy (discussed)
  • Vision improved to 20/40 by follow-up

ICD-10-CM Coding:

  • G35 - Multiple sclerosis (PRIMARY - this is MS relapse)
  • H46.11 - Retrobulbar neuritis, right eye (SECONDARY - current acute event)
  • H47.212 - Primary optic atrophy, left eye (SECONDARY - residual from prior episode, if coding sequelae)

CPT Coding:

  • 99215 - Office visit, established patient, high complexity (OR hospital codes if admitted)
  • 70543 - MRI orbits with and without contrast
  • 96365 - IV methylprednisolone infusion (if done outpatient)

Rationale: In known MS patient with optic neuritis relapse, MS (G35) is primary diagnosis. Optic neuritis (H46.11) is secondary, representing acute manifestation of MS activity. Specific type (retrobulbar) documented so use H46.11 instead of H46.9.

Example 4: Bilateral Optic Neuritis - Concerning for NMOSD

Clinical Scenario: 25-year-old woman presents with severe bilateral vision loss.

History:

  • 3 days ago: Rapid onset vision loss both eyes simultaneously
  • Severe pain both eyes with movement
  • Progressive worsening, now barely able to see
  • No prior similar episodes

Examination:

  • Visual acuity: Right eye light perception, left eye 20/400 (SEVERE)
  • RAPDs difficult to assess (bilateral involvement)
  • Fundus: Bilateral severe optic disc edema with peripapillary hemorrhages
  • Marked disc swelling both eyes

MRI Brain/Orbits:

  • Bilateral optic nerve enhancement
  • Longitudinally extensive optic nerve involvement (involving chiasm and optic tracts)
  • Longitudinally extensive transverse myelitis (cervical/thoracic spinal cord lesion extending >3 vertebral segments)
  • Concerning for neuromyelitis optica spectrum disorder

Serology:

  • AQP4-IgG (aquaporin-4 antibody): POSITIVE
  • Confirms neuromyelitis optica spectrum disorder (NMOSD)

Assessment:

  • Neuromyelitis optica spectrum disorder (NMOSD/Devic disease)
  • Bilateral severe optic neuritis (NMO-related)
  • Transverse myelitis

Treatment:

  • High-dose IV methylprednisolone 1000mg daily x 5 days
  • Plasma exchange (PLEX) for steroid-refractory vision loss
  • Start immunosuppression: Rituximab (Rituxan)
  • Neurology inpatient admission

ICD-10-CM Coding:

  • G36.0 - Neuromyelitis optica [Devic] (PRIMARY - specific diagnosis)
  • H46.03 - Optic papillitis, bilateral (SECONDARY - manifestation, if coding eye involvement specifically)
  • G37.3 - Acute transverse myelitis (if coding myelitis separately, though may be included in G36.0)

Alternative:

  • G36.0 - Neuromyelitis optica (PRIMARY)
  • H46.9 - Unspecified optic neuritis (SECONDARY) - if using unspecified code

Rationale: NMOSD is a specific diagnosis distinct from MS, coded as G36.0 (not G35). Bilateral severe optic neuritis is characteristic of NMOSD. Optic neuritis code (H46.03 or H46.9) may be added as secondary to document eye involvement, but G36.0 is the primary diagnosis. More specific H46.03 preferred if papillitis documented.

Example 5: Optic Neuritis - Retrobulbar Neuritis Specified

Clinical Scenario: 35-year-old male with acute vision loss, retrobulbar neuritis explicitly documented.

History:

  • 4-day history vision loss right eye
  • Eye pain with movement
  • No other symptoms

Examination:

  • Visual acuity: Right eye 20/60
  • RAPD right eye
  • Fundus: Right optic disc appears completely normal (no edema, no hyperemia)
  • Documentation explicitly states: “Retrobulbar neuritis, right eye”

MRI:

  • Right optic nerve enhancement (posterior to disc)
  • No brain lesions

Assessment:

  • Retrobulbar neuritis, right eye
  • Idiopathic (no MS lesions currently)

ICD-10-CM Coding:

  • H46.11 - Retrobulbar neuritis, right eye (PRIMARY - specific type documented)

NOT:

  • H46.9 - Unspecified optic neuritis (less specific; don’t use when specific type documented)

Rationale: When documentation explicitly specifies “retrobulbar neuritis,” use H46.11 (right eye), NOT H46.9. Always code to highest level of specificity available in documentation. H46.9 should only be used when type (papillitis vs retrobulbar) not specified or laterality not documented.

Example 6: Toxic Optic Neuropathy - NOT Coded as H46.9

Clinical Scenario: 55-year-old man with tuberculosis being treated with ethambutol develops bilateral vision loss.

History:

  • On ethambutol for TB treatment for 4 months
  • Gradual onset bilateral vision loss over past 2 months
  • Painless (no eye pain)
  • Central blur both eyes

Examination:

  • Visual acuity: Right eye 20/80, left eye 20/100
  • Bilateral cecocentral scotomas on visual fields
  • Fundus: Bilateral optic disc pallor (suggests chronic process)
  • Color vision markedly reduced bilaterally

Assessment:

  • Ethambutol-induced toxic optic neuropathy
  • Not typical inflammatory optic neuritis (painless, bilateral, chronic, drug-related)

Plan:

  • Discontinue ethambutol immediately
  • Switch TB regimen
  • Vision may or may not improve

INCORRECT Coding:

  • H46.9 - Unspecified optic neuritis (WRONG - this is TOXIC, not inflammatory)

CORRECT ICD-10-CM Coding:

  • T37.1X5A - Adverse effect of antimycobacterial drugs, initial encounter (PRIMARY - code the drug poisoning first)
  • H46.3 - Toxic optic neuropathy (SECONDARY - manifestation)
  • A15.9 - Respiratory tuberculosis unspecified (TERTIARY - underlying condition being treated)

Rationale: Toxic optic neuropathy from ethambutol is coded as H46.3, NOT H46.9. Per ICD-10 guidelines, code first the drug poisoning/adverse effect (T37.1X5A), then the manifestation (H46.3). This is distinct from inflammatory/demyelinating optic neuritis.

Example 7: Query Physician When Type Unspecified

Clinical Scenario: Documentation states: “Patient has optic neuritis.”

Problem:

  • Type not specified (papillitis vs retrobulbar?)
  • Laterality not specified (which eye?)
  • No details on disc appearance

Query Physician: “Documentation indicates patient has optic neuritis. Please clarify:

  1. Type: Is this optic papillitis (disc swelling present) or retrobulbar neuritis (disc appears normal)?
  2. Laterality: Which eye is affected - right eye, left eye, or bilateral?
  3. If bilateral, are both eyes equally affected or asymmetric?

This information is needed for accurate ICD-10 coding:

  • H46.01 = Optic papillitis, right eye
  • H46.02 = Optic papillitis, left eye
  • H46.11 = Retrobulbar neuritis, right eye
  • H46.12 = Retrobulbar neuritis, left eye
  • H46.9 = Unspecified optic neuritis (if above details cannot be determined)”

If Physician Clarifies:

  • “Retrobulbar neuritis, right eye” → Code H46.11
  • “Optic papillitis, left eye” → Code H46.02

If Physician Unable to Specify:

  • Code H46.9 (unspecified optic neuritis)
Example 8: Ischemic Optic Neuropathy Misdiagnosed as Optic Neuritis

Clinical Scenario: 68-year-old man presents with sudden vision loss right eye.

Initial Assessment (Incorrect):

  • “Optic neuritis” documented initially

Actual Clinical Features:

  • Painless vision loss (red flag - ON usually painful)
  • Sudden onset upon awakening (woke up blind in right eye)
  • Age 68 (older than typical ON)
  • Hypertension, diabetes, sleep apnea
  • Optic disc swollen with altitudinal pattern

Correct Diagnosis:

  • Non-arteritic ischemic optic neuropathy (NAION)
  • NOT optic neuritis (no pain, older age, vascular risk factors, sudden onset, altitudinal defect)

INCORRECT Coding:

  • H46.9 - Optic neuritis (WRONG diagnosis)

CORRECT ICD-10-CM Coding:

  • H47.011 - Ischemic optic neuropathy, right eye (CORRECT)
  • I10 - Essential hypertension (risk factor)
  • E11.9 - Type 2 diabetes (risk factor)

Rationale: Not all optic nerve problems are optic neuritis. Ischemic optic neuropathy (H47.01-) has different pathophysiology (vascular occlusion) and different coding. Clinical features distinguish: NAION is painless, sudden, older age, vascular risk factors, altitudinal defects. Query if documentation says “optic neuritis” but clinical features suggest ischemic neuropathy.

Documentation Requirements

Essential Documentation for H46.9:

1. Confirm Clinical Diagnosis of Optic Neuritis:

Must document clinical features:

Classic Triad:

  • Subacute vision loss: “Vision loss developing over 2-3 days in right eye”
  • Eye pain with movement: “Retro-orbital pain worse with eye movements”
  • Dyschromatopsia: “Red color desaturation right eye”

Example Statement: “32-year-old female presents with 3-day history of progressive vision loss in right eye associated with pain on eye movement. Color vision testing demonstrates red desaturation in affected eye. Examination findings consistent with optic neuritis.”

2. Document Ophthalmologic Examination Findings:

Visual Acuity:

  • “Visual acuity: Right eye 20/80, left eye 20/20”

Pupils - ESSENTIAL:

  • Relative afferent pupillary defect (RAPD): “Swinging flashlight test demonstrates relative afferent pupillary defect in right eye (Marcus Gunn pupil present)”
  • RAPD is hallmark finding and must be documented

Fundus Examination:

  • Describe optic disc appearance:
    • “Right optic disc appears normal without edema or hyperemia” (suggests retrobulbar neuritis)
    • OR “Right optic disc demonstrates edema with blurred margins and hyperemia” (suggests papillitis)
  • If using H46.9 (unspecified), disc appearance may not be specified, but should be examined

Color Vision:

  • “Ishihara color plates reduced in right eye”
  • “Red cap test shows red desaturation right eye compared to left”

Visual Fields:

  • “Central scotoma right eye on confrontation testing”
  • “Humphrey 24-2 demonstrates central visual field defect right eye”

3. Document Laterality:

  • Must specify which eye affected: “right eye,” “left eye,” or “bilateral”
  • Even if coding H46.9 (unspecified), clinical notes should document laterality

4. Document Pain:

  • “Pain on eye movement” or “retro-orbital pain”
  • “Pain worse with any direction of gaze”
  • Present in ~90% of cases; if absent, note “no pain” (atypical feature)

5. Document Acute/Subacute Onset:

  • “Onset over hours to days” (typical)
  • “Symptoms developed over 3-day period”
  • “Patient noticed vision loss starting 2 days ago, progressively worsening”

6. Diagnostic Testing (When Performed):

MRI Brain/Orbits with Gadolinium:

  • “MRI orbits demonstrates right optic nerve enhancement consistent with acute optic neuritis”
  • “MRI brain demonstrates five periventricular white matter lesions concerning for demyelinating disease”
  • “MRI brain normal, no white matter lesions identified”

Visual Evoked Potentials:

  • “VEP demonstrates prolonged P100 latency right eye (135 milliseconds, abnormal)”

OCT:

  • “OCT demonstrates peripapillary retinal nerve fiber layer thickening right eye (average 110 microns)”

Lumbar Puncture (if performed):

  • “CSF analysis demonstrates oligoclonal bands present (absent in serum)”

7. Document Associated Conditions:

  • If MS suspected/confirmed: “Patient meets McDonald criteria for multiple sclerosis” → Code G35 additionally
  • If first episode: “First episode of optic neuritis, no prior demyelinating events”
  • If recurrent: “Recurrent optic neuritis, prior episode 3 years ago”

8. Rule Out Alternative Diagnoses:

  • “No features of ischemic optic neuropathy (patient age 32, painful, subacute onset)”
  • “No compressive lesion identified on MRI”
  • “Giant cell arteritis ruled out (age 32, ESR normal)”

9. Treatment Plan:

  • “IV methylprednisolone 1000mg daily x 3 days recommended per ONTT protocol”
  • “Patient electing observation with close follow-up”
  • “Neurology consultation requested for MS evaluation”

10. Assessment Statement:

  • Clear diagnosis: “Optic neuritis, right eye”
  • If type specified: “Retrobulbar neuritis, right eye” or “Optic papillitis, right eye”
Complete Documentation Example (Supports H46.9 or More Specific Code):

“32-year-old female presents with acute vision loss right eye. Patient reports onset 3 days ago of progressive blurring of vision in right eye, worsening over 48-72 hours. Associated with pain behind right eye, significantly worse with eye movements in any direction. Patient notes that red colors appear ‘washed out’ compared to left eye. No prior similar episodes. No other neurologic symptoms. No headache, fever, or systemic symptoms.

Examination: Best-corrected visual acuity 20/80 right eye, 20/20 left eye. Pupils: Swinging flashlight test demonstrates relative afferent pupillary defect (RAPD) in right eye, with paradoxical dilation when light swung from left to right eye (Marcus Gunn pupil present). Color vision testing with red cap shows marked desaturation in right eye compared to left. Visual field testing by confrontation suggests central scotoma right eye. Extraocular motility full bilaterally but right eye painful with all movements. Slit lamp examination: Normal anterior segments bilaterally, no anterior chamber cells. Dilated fundus examination: Right optic disc appears normal without edema or hyperemia, cup-to-disc ratio 0.3, disc margins well-defined. No peripapillary hemorrhages. Right macula normal. Left optic disc and macula normal. Retinal vasculature normal bilaterally.

Clinical diagnosis: Optic neuritis, right eye. Classic presenting features include subacute monocular vision loss, pain with eye movement, relative afferent pupillary defect, and dyschromatopsia. Normal-appearing optic disc suggests retrobulbar location of inflammation. Differential diagnosis includes demyelinating optic neuritis (most likely given age and presentation), though ischemic optic neuropathy, compressive lesion, and other inflammatory conditions considered but less likely given clinical features.

Plan: MRI brain and orbits with gadolinium contrast ordered to confirm optic neuritis (evaluate for optic nerve enhancement) and assess for demyelinating brain lesions suggestive of multiple sclerosis. Neurology consultation requested for MS risk stratification and consideration of disease-modifying therapy if MRI demonstrates white matter lesions. Treatment options discussed with patient including high-dose intravenous methylprednisolone (1000mg daily for 3 days) per Optic Neuritis Treatment Trial protocol, which accelerates visual recovery but does not affect final visual outcome. Patient counseled that most patients with typical optic neuritis experience spontaneous improvement within weeks to months, with approximately 95% regaining useful vision. Discussed that oral prednisone alone not recommended based on ONTT findings showing increased recurrence risk. Patient elects to proceed with IV methylprednisolone therapy. Advised to avoid oral prednisone as sole treatment. Return to ophthalmology clinic in 1 week for reassessment of visual acuity and examination. Visual field testing and OCT imaging will be obtained at follow-up visit to establish baseline and monitor for improvement. Patient educated regarding association between optic neuritis and multiple sclerosis, with discussion that approximately 50% of patients with optic neuritis and abnormal brain MRI will develop MS within 15 years, while risk is lower (~25%) with normal brain MRI. Instructed to report immediately if develops new neurologic symptoms including numbness, weakness, balance problems, double vision, or bladder dysfunction, which could indicate MS or other demyelinating event. Patient counseled regarding expected course with stabilization of vision loss over 1-2 weeks followed by gradual improvement over subsequent weeks to months. Uhthoff phenomenon (heat sensitivity with temporary vision worsening) discussed. Patient understands diagnosis, treatment plan, prognosis, and warning signs. All questions answered. Written instructions provided.

ICD-10 Coding: H46.9 (Unspecified optic neuritis) - may be updated to more specific code (H46.11 retrobulbar neuritis, right eye) after MRI confirmation. Will add G35.- (Multiple sclerosis) if MS criteria met based on MRI and clinical findings.”

Insufficient Documentation Examples:

Example 1 - Insufficient: “Patient has optic neuritis.”

  • Missing: Laterality (which eye?)
  • Missing: Clinical features (vision loss, pain, RAPD)
  • Missing: Examination findings (pupils, fundus)
  • Missing: Onset/duration
  • Cannot code without adequate documentation

Example 2 - Insufficient: “Vision loss right eye, disc swollen.”

  • Missing: Pain documentation (was it present?)
  • Missing: RAPD assessment (critical finding)
  • Missing: Color vision testing
  • Missing: Acute vs chronic onset
  • Missing: Assessment (is this optic neuritis, or papilledema, or ischemic neuropathy?)
  • Insufficient to support diagnosis code

Example 3 - Insufficient: “Optic neuritis treated with steroids.”

  • Missing: Which eye?
  • Missing: Examination findings
  • Missing: Supporting diagnostic features
  • Missing: Type (papillitis vs retrobulbar)
  • Cannot determine appropriate code
When to Query Physician:

Query for Type Specification: “Documentation notes ‘optic neuritis’ without specifying type. Please clarify:

  • Is this optic papillitis (disc edema/swelling present on fundoscopy)?
  • Is this retrobulbar neuritis (disc appears normal on fundoscopy)?
  • Type cannot be determined?

This determines whether to code:

  • H46.0- (optic papillitis with laterality)
  • H46.1- (retrobulbar neuritis with laterality)
  • H46.9 (unspecified optic neuritis)”

Query for Laterality: “Documentation indicates optic neuritis. Please specify which eye is affected:

  • Right eye only → H46.11 (if retrobulbar) or H46.01 (if papillitis)
  • Left eye only → H46.12 (if retrobulbar) or H46.02 (if papillitis)
  • Bilateral → H46.13 (if retrobulbar) or H46.03 (if papillitis)
  • Unspecified → H46.9”

Query to Confirm Diagnosis: “Documentation mentions vision loss and disc swelling. Please clarify diagnosis:

  • Is this inflammatory optic neuritis (H46.-)?
  • Is this ischemic optic neuropathy (H47.01-)?
  • Is this papilledema from increased intracranial pressure (H47.1-)?
  • Is this compressive optic neuropathy? Clinical features that help distinguish: presence/absence of eye pain, age, onset (sudden vs subacute), RAPD, unilateral vs bilateral.”

Query for Underlying Etiology: “Optic neuritis documented. Please clarify if underlying cause identified:

  • Associated with multiple sclerosis (also code G35)?
  • Associated with neuromyelitis optica (code G36.0 as primary)?
  • Idiopathic/demyelinating (H46.- code alone)?
  • Infectious/post-infectious cause (add infectious disease code)?
  • Drug-induced or toxic (H46.3 instead of H46.9, code poisoning first)?”

Query for Pain: “Documentation states vision loss but does not mention presence or absence of pain. Pain on eye movement is present in 90% of optic neuritis cases. Please document:

  • Was eye pain present or absent?
  • Was pain worse with eye movements? Absence of pain raises possibility of alternative diagnosis (ischemic optic neuropathy, compressive lesion).”

Query for RAPD: “Optic neuritis documented but RAPD (relative afferent pupillary defect) not mentioned. RAPD is hallmark finding in unilateral optic neuritis. Please document:

  • Was swinging flashlight test performed?
  • Was RAPD present or absent?
  • If absent with unilateral vision loss, consider alternative diagnosis.”

Billing and Coding Considerations

When to Use H46.9:

Appropriate Use:

  • Optic neuritis diagnosed clinically but specific type not documented (papillitis vs retrobulbar not specified)
  • Laterality not documented in coding (though clinical notes should specify)
  • Patient in acute phase and full characterization not yet complete
  • Type cannot be determined from available documentation
  • Default/unspecified optic neuritis code

Use More Specific Codes When Documented:

  • H46.01 (optic papillitis, right eye) - if papillitis and laterality documented
  • H46.11 (retrobulbar neuritis, right eye) - if retrobulbar type and laterality documented
  • Always code to highest level of specificity available
Medical Necessity:

H46.9 Supports:

  • Emergency department or urgent office visit for acute vision loss evaluation
  • Comprehensive ophthalmologic examination with dilated fundus exam
  • Neurologic consultation for MS evaluation
  • MRI brain and orbits with gadolinium contrast:
    • Confirms optic neuritis (optic nerve enhancement)
    • Assesses MS risk (white matter lesions)
    • Rules out compressive lesions
    • Essential for diagnosis and risk stratification
  • Visual evoked potentials (VEP): Confirms optic nerve dysfunction
  • OCT imaging: Documents RNFL changes (swelling acutely, thinning chronically)
  • Visual field testing: Quantifies functional deficit, monitors recovery
  • Lumbar puncture: If MS suspected and MRI non-diagnostic
  • Inpatient admission (if severe, requiring IV steroids with monitoring)
  • IV methylprednisolone therapy: 1000mg daily x 3 days (ONTT protocol)
  • Serial follow-up visits: Monitor visual recovery, assess for MS development
  • Disease-modifying therapy for MS: If MS diagnosed or high-risk findings
Treatment Documentation:

Acute Phase:

  • IV steroids: “IV methylprednisolone 1000mg daily x 3 days, followed by oral prednisone 1mg/kg/day x 11 days with taper”
  • Observation: “Patient electing observation without steroids given mild presentation and good prognostic features”
  • Medical necessity: “IV steroids recommended to accelerate visual recovery per ONTT protocol”

MS Evaluation:

  • “MRI demonstrates 5 periventricular white matter lesions consistent with demyelinating disease”
  • “Neurology consultation: Patient meets 2017 McDonald criteria for MS”
  • “Starting dimethyl fumarate (Tecfidera) for MS disease-modifying therapy”

Follow-up Plan:

  • “Return in 1 week for visual acuity assessment”
  • “Repeat MRI brain in 6-12 months for MS surveillance”
  • “Neurology follow-up every 3 months”
Payer Considerations:

Medicare:

  • Covers medically necessary optic neuritis evaluation and treatment
  • MRI brain/orbits covered with appropriate indication
  • IV steroids covered (inpatient or hospital-based outpatient)
  • VEP covered
  • OCT and visual fields covered for monitoring
  • MS disease-modifying therapy covered under Part B (infusions) or Part D (oral/injectable)

Commercial Insurance:

  • Generally covers optic neuritis workup
  • Prior authorization may be required for:
    • MRI (some plans)
    • Lumbar puncture
    • Inpatient admission (must demonstrate medical necessity)
    • MS disease-modifying therapy (step therapy, prior authorization common)
  • Document medical necessity clearly

Inpatient vs Outpatient:

  • Most optic neuritis managed OUTPATIENT
  • Inpatient admission justified if:
    • Severe vision loss requiring IV steroids with monitoring
    • Extensive workup needed (MRI, LP, multiple consultations)
    • First demyelinating event requiring MS evaluation
    • Steroid complications (hyperglycemia, psychiatric symptoms)
    • Social factors (unable to receive outpatient infusion)
  • Document reason for admission clearly for MS-DRG 123 reimbursement
Common Billing Errors:

  1. Using H46.9 when specific type documented:

    • If note says “retrobulbar neuritis, right eye,” code H46.11 (not H46.9)
    • If note says “optic papillitis, left eye,” code H46.02 (not H46.9)
    • Always use most specific code available

  2. Coding ischemic neuropathy as optic neuritis:

    • Ischemic optic neuropathy (NAION, AAION) is H47.01-, NOT H46.-
    • Different pathophysiology (vascular vs inflammatory)
    • Clinical features distinguish: NAION painless, sudden, older age, vascular risk factors
    • Query if “optic neuritis” documented but features suggest ischemic cause

  3. Coding toxic/nutritional neuropathy as H46.9:

    • Toxic optic neuropathy → H46.3 (code poisoning/drug first)
    • Nutritional optic neuropathy → H46.2
    • Different etiology from inflammatory/demyelinating optic neuritis
    • Review medication history, nutritional status

  4. Not coding MS when diagnosed:

    • If MS diagnosed, code G35 as primary or comorbidity (depending on encounter reason)
    • Optic neuritis (H46.-) may be secondary if documenting eye manifestation
    • MS is primary disease; optic neuritis is manifestation

  5. Billing MRI without medical necessity:

    • Must document indication: “MRI ordered to confirm optic neuritis and assess for MS”
    • Not just “imaging obtained”
    • Link to diagnosis code (H46.9)

  6. Billing bilateral procedures with unilateral diagnosis:

    • If only right eye affected, don’t bill bilateral OCT or VF without justification
    • May test fellow eye to detect subclinical involvement
    • Document rationale: “Fellow eye tested to assess for subclinical optic nerve involvement”

  7. Not updating diagnosis when more information available:

    • Initial visit: H46.9 (unspecified optic neuritis)
    • After MRI confirms retrobulbar neuritis: Update to H46.11 (retrobulbar neuritis, right eye)
    • After MS diagnosed: Add G35
    • Diagnosis should evolve as workup progresses

  8. Using optic neuritis code for chronic sequelae:

    • H46.- codes for ACUTE inflammatory optic neuritis
    • Chronic optic atrophy from prior optic neuritis → H47.2- (optic atrophy)
    • Chronic vision impairment from prior optic neuritis → H54.- (vision impairment/blindness)
    • Don’t continue coding H46.9 years after acute episode resolved

  9. Inadequate documentation for inpatient admission:

    • Must justify why outpatient management insufficient
    • Document severity, need for IV steroids, need for comprehensive workup
    • MS-DRG 123 requires clear medical necessity for admission

  10. Not linking procedures to diagnosis:

    • All testing must be linked to H46.9 diagnosis
    • MRI, VEP, OCT, visual fields for optic neuritis evaluation
    • Medical necessity demonstrated by diagnosis code
Best Practices:

Documentation:

  • Complete examination with RAPD, fundus description, color vision
  • Specify laterality (right, left, bilateral)
  • Document type if possible (papillitis vs retrobulbar)
  • Rule out alternative diagnoses (ischemic, compressive, infectious)
  • Document MS risk assessment (MRI findings, CSF if done)
  • Treatment plan with rationale (IV steroids vs observation)
  • Follow-up plan clearly stated

Coding:

  • Use most specific code available (H46.01, H46.11 if type/laterality documented)
  • Use H46.9 only when specific type not documented or cannot be determined
  • Add G35 if MS diagnosed
  • Update codes as workup progresses and more information available
  • Don’t use H46.- for chronic sequelae (use H47.2- for optic atrophy, H54.- for vision loss)

Billing:

  • Link all testing to optic neuritis diagnosis
  • Document medical necessity for MRI, advanced testing
  • Prior authorization when required
  • Justify inpatient admission if admitted
  • Code appropriately for MS-DRG 123 if inpatient

Quality Metrics:

  • Timely MRI within 2 weeks of presentation
  • Neurology consultation for MS evaluation
  • Appropriate steroid therapy when indicated
  • Follow-up to assess visual recovery
  • MS surveillance and treatment initiation if indicated

Summary

H46.9 (Unspecified Optic Neuritis) Key Points:

Clinical:

  • Acute inflammatory demyelinating condition of optic nerve
  • Classic triad: Subacute monocular vision loss + eye pain with movement + RAPD
  • Most common in young women age 20-45
  • Strongly associated with multiple sclerosis (15-20% presenting symptom, 50% develop MS)
  • Most patients recover spontaneously (95% regain useful vision)
  • RAPD is hallmark finding

Diagnostic Criteria:

  1. Subacute vision loss (hours to days onset)
  2. Eye pain with movement (~90%)
  3. RAPD present (if unilateral)
  4. Dyschromatopsia (red desaturation)
  5. Age 15-50 typical
  6. MRI confirms (optic nerve enhancement)

Treatment:

  • IV methylprednisolone 1000mg daily x 3 days (accelerates recovery, doesn’t change final outcome)
  • DO NOT use oral prednisone alone (increased recurrence risk per ONTT)
  • Observation acceptable for mild cases
  • MS disease-modifying therapy if MS diagnosed

Coding:

  • H46.9 = Unspecified optic neuritis (default/non-specific code)
  • Use more specific codes when documented:
    • H46.0- (optic papillitis with laterality)
    • H46.1- (retrobulbar neuritis with laterality)
  • Add G35 if MS diagnosed
  • Do NOT use H46.9 for:
    • Ischemic optic neuropathy (H47.01-)
    • Toxic optic neuropathy (H46.3)
    • Nutritional optic neuropathy (H46.2)

MS-DRG: 123 (Neurological Eye Disorders) if inpatient admission

HCC: Does NOT map to HCC

Documentation: Must document vision loss, eye pain, RAPD, fundus appearance, laterality, and rule out alternative diagnoses

Prognosis:

  • Excellent visual recovery in most cases (95% regain useful vision)
  • 50% risk of MS development within 15 years if abnormal brain MRI (≄3 lesions)
  • 25% risk if normal brain MRI
  • May recur (20-30% have second episode in either eye)

This completes the comprehensive documentation for ICD-10-CM code H46.9 (Unspecified Optic Neuritis).

Graph View

Recent Notes